FDA Discontinuation of HRT Warning is a Poor Choice for Women
November 10, 2025
November 10, 2025
WASHINGTON, Nov. 10 [Category: Health Care] -- Physicians Committee for Responsible Medicine posted the following news release:
* * *
FDA Discontinuation of HRT Warning is a Poor Choice for Women
*
Barnard Medical Center Clinical Director Vanita Rahman, MD, responds to the FDA announcement that it will discontinue its warning label on menopausal hormone therapy. The FDA's recent decision to remove warnings about breast cancer, heart attack . . .
* * *
FDA Discontinuation of HRT Warning is a Poor Choice for Women
*
Barnard Medical Center Clinical Director Vanita Rahman, MD, responds to the FDA announcement that it will discontinue its warning label on menopausal hormone therapy. The FDA's recent decision to remove warnings about breast cancer, heart attack . . .